Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Icecure Medical Ltd ICCM

Healthcare Medical Care Medical Devices
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ICCM)

IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer

PR Newswire 3 days ago

IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense® and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast Cancer Study Data to FDA this Month for Marketing Clearance

PR Newswire April 3, 2024

IceCure Submits FDA Regulatory Filing for New XSense(TM) Cryoablation System with Cryoprobes

PR Newswire April 2, 2024

IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024

PR Newswire March 27, 2024

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy

PR Newswire March 19, 2024

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes

PR Newswire March 12, 2024

IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference

PR Newswire March 7, 2024

IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024

PR Newswire March 4, 2024

Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop

PR Newswire February 27, 2024
View More News ››

Opinion & Analysis (NDAQ:ICCM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ICCM)

IceCure Medical Requests Marketing Authorization to Treat Ea

News; $ICCM IceCure Medical Requests Marketing Authorization to Treat Early-Stage Breast Cancer from FDA2024-04-15 10:06:29 ET DENVER...
whytestocks - 3 days ago

ICCM.....1st scalp of the a.m ; )

Call it "Lunch Money" 
Iseneschal - 3 days ago

Fourth BRIIT Conference in India Features IceCure's ProSense

Breaking News: $ICCM Fourth BRIIT Conference in India Features IceCure's ProSense&#xAE; in Breast Cancer Imaging &...
whytestocks - February 27, 2024

An unbelievable N.R. and nothing.

Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
billybob22 - February 27, 2024

RE:New Press Release - Study Using IceCure's ProSense&#xAE; Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"

Another great news release but the stock drops..............
billybob22 - December 13, 2023

ICCM .... N.H.O.D $1.49 Tuesday !!!!!!!

That $1.49 could be the next 649 Lotto JMHO
Iseneschal - November 28, 2023
View more Bullboard ››

Grounded Lithium Corp

Grounded Lithium Corp

Grounded Lithium Corp. is a Canada-based lithium brine exploration and development company. The Company is focused on ...
View More »